DE602004015272D1 - Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase - Google Patents
Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blaseInfo
- Publication number
- DE602004015272D1 DE602004015272D1 DE602004015272T DE602004015272T DE602004015272D1 DE 602004015272 D1 DE602004015272 D1 DE 602004015272D1 DE 602004015272 T DE602004015272 T DE 602004015272T DE 602004015272 T DE602004015272 T DE 602004015272T DE 602004015272 D1 DE602004015272 D1 DE 602004015272D1
- Authority
- DE
- Germany
- Prior art keywords
- hyperactive
- bubble
- treatment
- acid derivatives
- phenoxy acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002253 acid Substances 0.000 title 1
- KHUXNRRPPZOJPT-UHFFFAOYSA-N phenoxy radical Chemical class O=C1C=C[CH]C=C1 KHUXNRRPPZOJPT-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/191—Carboxylic acids, e.g. valproic acid having two or more hydroxy groups, e.g. gluconic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10320084A DE10320084A1 (de) | 2003-05-05 | 2003-05-05 | Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase |
DE2003123837 DE10323837A1 (de) | 2003-05-23 | 2003-05-23 | Verwendung von Phenoxyessigsäurederivaten zur Behandlung der hyperaktiven Blase |
PCT/JP2004/004048 WO2004098586A1 (en) | 2003-05-05 | 2004-03-24 | Use of phenoxyacetic acid derivatives for treating hyperactive bladder |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004015272D1 true DE602004015272D1 (de) | 2008-09-04 |
Family
ID=33420009
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004015272T Expired - Lifetime DE602004015272D1 (de) | 2003-05-05 | 2004-03-24 | Verwendung von phenoxyessigsäurederivaten zur behandlung der hyperaktiven blase |
Country Status (26)
Country | Link |
---|---|
US (1) | US20040229947A1 (de) |
EP (1) | EP1620085B1 (de) |
JP (1) | JP4602969B2 (de) |
KR (1) | KR101052804B1 (de) |
AR (1) | AR044169A1 (de) |
AT (1) | ATE401878T1 (de) |
AU (1) | AU2004236596B2 (de) |
BR (1) | BRPI0409980A (de) |
CA (1) | CA2524023C (de) |
CL (1) | CL2004000952A1 (de) |
CY (1) | CY1108425T1 (de) |
DE (1) | DE602004015272D1 (de) |
DK (1) | DK1620085T3 (de) |
ES (1) | ES2309513T3 (de) |
IL (1) | IL171713A (de) |
MX (1) | MXPA05011862A (de) |
MY (1) | MY141756A (de) |
NZ (1) | NZ543347A (de) |
PE (1) | PE20050524A1 (de) |
PL (1) | PL1620085T3 (de) |
PT (1) | PT1620085E (de) |
RU (1) | RU2342133C2 (de) |
SI (1) | SI1620085T1 (de) |
TW (1) | TWI351279B (de) |
UY (1) | UY28306A1 (de) |
WO (1) | WO2004098586A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI356699B (en) | 2004-11-10 | 2012-01-21 | Kissei Pharmaceutical | Agent for treating interstitial cystitis and agent |
CA2605298A1 (en) * | 2005-04-26 | 2006-11-09 | Kissei Pharmaceutical Co., Ltd. | Crystal of hydroxynorephedrin derivative hydrochloride 1/4 hydrate |
US7763654B2 (en) * | 2005-04-26 | 2010-07-27 | Kissei Pharmaceutical Co., Ltd. | Crystal polymorph of hydroxynorephedrin derivative hydrochloride |
EP1769792A1 (de) * | 2005-09-30 | 2007-04-04 | Boehringer Ingelheim Pharma GmbH & Co.KG | Verwendung eines beta-3-Adrenozeptor-Agonisten zur Behandlung von Nieren- und Blasenbeschwerden |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6262115B1 (en) * | 1995-05-22 | 2001-07-17 | Alza Coporation | Method for the management of incontinence |
US6720014B1 (en) * | 1997-08-13 | 2004-04-13 | Diversa Corporation | Phytase-containing foodstuffs and methods of making and using them |
MY126489A (en) * | 1998-07-08 | 2006-10-31 | Kissei Pharmaceutical | Phenoxyacetic acid derivatives and medicinal compositions containing the same |
DE60041110D1 (de) * | 1999-11-01 | 2009-01-29 | Sumitomo Chemical Co | 6-Hydroxy-5,6-dihydrouracile als Herbizide |
CA2458544C (en) * | 2001-09-13 | 2010-08-17 | Kissei Pharmaceutical Co., Ltd. | Crystals of hydroxynorephedrine derivative |
-
2004
- 2004-03-24 CA CA2524023A patent/CA2524023C/en not_active Expired - Fee Related
- 2004-03-24 DE DE602004015272T patent/DE602004015272D1/de not_active Expired - Lifetime
- 2004-03-24 WO PCT/JP2004/004048 patent/WO2004098586A1/en active IP Right Grant
- 2004-03-24 ES ES04722967T patent/ES2309513T3/es not_active Expired - Lifetime
- 2004-03-24 PL PL04722967T patent/PL1620085T3/pl unknown
- 2004-03-24 RU RU2005137701/15A patent/RU2342133C2/ru not_active IP Right Cessation
- 2004-03-24 EP EP04722967A patent/EP1620085B1/de not_active Expired - Lifetime
- 2004-03-24 DK DK04722967T patent/DK1620085T3/da active
- 2004-03-24 BR BRPI0409980-0A patent/BRPI0409980A/pt not_active IP Right Cessation
- 2004-03-24 AT AT04722967T patent/ATE401878T1/de active
- 2004-03-24 MX MXPA05011862A patent/MXPA05011862A/es active IP Right Grant
- 2004-03-24 JP JP2006507687A patent/JP4602969B2/ja not_active Expired - Fee Related
- 2004-03-24 PT PT04722967T patent/PT1620085E/pt unknown
- 2004-03-24 KR KR1020057020792A patent/KR101052804B1/ko not_active IP Right Cessation
- 2004-03-24 NZ NZ543347A patent/NZ543347A/en not_active IP Right Cessation
- 2004-03-24 AU AU2004236596A patent/AU2004236596B2/en not_active Ceased
- 2004-03-24 SI SI200430884T patent/SI1620085T1/sl unknown
- 2004-03-26 US US10/809,346 patent/US20040229947A1/en not_active Abandoned
- 2004-04-21 TW TW093111093A patent/TWI351279B/zh not_active IP Right Cessation
- 2004-04-30 MY MYPI20041651A patent/MY141756A/en unknown
- 2004-05-04 CL CL200400952A patent/CL2004000952A1/es unknown
- 2004-05-05 PE PE2004000459A patent/PE20050524A1/es not_active Application Discontinuation
- 2004-05-05 UY UY28306A patent/UY28306A1/es unknown
- 2004-05-05 AR ARP040101519A patent/AR044169A1/es not_active Application Discontinuation
-
2005
- 2005-11-01 IL IL171713A patent/IL171713A/en not_active IP Right Cessation
-
2008
- 2008-10-16 CY CY20081101158T patent/CY1108425T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AR044169A1 (es) | 2005-08-24 |
DK1620085T3 (da) | 2008-11-24 |
PL1620085T3 (pl) | 2009-01-30 |
PE20050524A1 (es) | 2005-07-07 |
NZ543347A (en) | 2008-05-30 |
CY1108425T1 (el) | 2014-04-09 |
IL171713A (en) | 2011-12-29 |
MY141756A (en) | 2010-06-30 |
CA2524023C (en) | 2011-11-22 |
PT1620085E (pt) | 2008-08-07 |
BRPI0409980A (pt) | 2006-05-09 |
KR20060009886A (ko) | 2006-02-01 |
TWI351279B (en) | 2011-11-01 |
AU2004236596B2 (en) | 2010-03-11 |
SI1620085T1 (sl) | 2008-12-31 |
KR101052804B1 (ko) | 2011-07-29 |
RU2005137701A (ru) | 2006-06-10 |
CL2004000952A1 (es) | 2005-03-04 |
RU2342133C2 (ru) | 2008-12-27 |
EP1620085B1 (de) | 2008-07-23 |
AU2004236596A1 (en) | 2004-11-18 |
MXPA05011862A (es) | 2006-02-17 |
EP1620085A1 (de) | 2006-02-01 |
CA2524023A1 (en) | 2004-11-18 |
JP4602969B2 (ja) | 2010-12-22 |
TW200509902A (en) | 2005-03-16 |
ES2309513T3 (es) | 2008-12-16 |
US20040229947A1 (en) | 2004-11-18 |
ATE401878T1 (de) | 2008-08-15 |
UY28306A1 (es) | 2004-12-31 |
JP2006525318A (ja) | 2006-11-09 |
WO2004098586A1 (en) | 2004-11-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005005810D1 (de) | Verwendung von substituierten chinolin-derivaten zur behandlung von arzneimittelresistenten mycobakteriellen erkrankungen | |
DE602005017503D1 (de) | Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen | |
DE60303238D1 (de) | Pyrimidin-Essigsäure Derivate geeignet zur Behandlung von CRTH2-bedingten Krankheiten | |
DE602005007717D1 (de) | Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen | |
ATE550338T1 (de) | Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit | |
ATE369333T1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
DE602005026984D1 (de) | Chinolin-derivate zur behandlung von latenter tuberkulose | |
ATE527241T1 (de) | Pyridiazinonderivate zur behandlung von tumoren | |
DE602005002930D1 (de) | Sulfonamidderivate zur behandlung von krankheiten | |
ATE476414T1 (de) | Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen | |
ATE438623T1 (de) | Aroyl-o-piperidinderivate zur behandlung von problemen im zusammenhang mit diabetes | |
ATE410430T1 (de) | 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose | |
ATE542536T1 (de) | 3-ä4-(dibenzoäb,füä1,4üoxazepin-11-yl)-piperazi - 1-ylü-2,2-dimethyl propansäure zur verwendung in der behandlung von schlafstörungen | |
DE602005027388D1 (de) | Malonsäureamidderivate als inhibitoren von g-sekretase zur behandlung von alzheimer-krankheit | |
DE602006017367D1 (de) | Amino-oxo-indolyliden-verbindungen zur verwendung in der behandlung von juckender kopfhaut | |
ATE439347T1 (de) | 7-(2h-pyrazol-3-yl)-3,5-dihydroxy-heptansäure- derivate als hmg-co-a-reductase-inhibitoren zur behandlung von lipidemia | |
DE602006007323D1 (de) | VERWENDUNG VON BAFF ZUR BEHANDLUNG Th2-INDUZIERTER LEIDEN | |
DE60130661D1 (de) | Verwendung der 13-cis retinsäure zur behandlung von emphysemen | |
DE602005016141D1 (de) | S-mirtazapin zur behandlung von hitzewallungen | |
DE602004022035D1 (de) | Verwendung von pthalide derivativen zur behandlung | |
DE602005027251D1 (de) | Sulfamide alsendothelinrezeptorantagonsiten zur behandlung von herzkreislauferkrankungen | |
DE60309719D1 (de) | N-substituierte-1h-indol-5-propansäure verbindungen als ppar-agonisten zur behandlung von diabetis | |
DE602004006118D1 (de) | 2,3,4,5-TETRAHYDROBENZOiFöi1,4öOXAZEPIN-5-CARBONSÄUREAMID DERIVATE ALS GAMMA-SECRETASE INHIBITOREN ZUR BEHANDLUNG VON ALZHEIMER | |
ATE482707T1 (de) | 1-ä2h-1-benzopyran-2-on-8-ylü- piperazin- derivate zur behandlung von schmerzen | |
ATE457725T1 (de) | Kynurenine 3-hydroxylase inhibitoren zur behandlung von diabetes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: WESTENDORP SOMMER, 80336 MUENCHEN |